Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
ANZ J Surg ; 89(5): E190-E194, 2019 05.
Article in English | MEDLINE | ID: mdl-30968539

ABSTRACT

BACKGROUND: Minimally invasive pancreaticoduodenectomy (PD) is a feasible option for periampullary tumours. However, it remains a complex procedure with no proven advantages over open PD (OPD). The aim of the study was to compare the outcomes between laparoscopic-assisted PD (LAPD) and OPD using a propensity score-matched analysis. METHODS: Retrospective review of 40 patients who underwent PD for periampullary tumours between January 2014 and December 2016 was conducted. The patients were matched 1:1 for age, gender, body mass index, Charlson comorbidty index, tumour size and haematological indices. Peri-operative outcomes were evaluated. RESULTS: LAPD appeared to have a longer median operative time as compared to OPD (LAPD, 425 min (285-597) versus OPD, 369 min (260-500)) (P = 0.066). Intra-operative blood loss was comparable between both groups. Respiratory complications were five times higher in the OPD group (LAPD, 5% versus OPD, 25%) (P = 0.077), while LAPD patients required less time to start ambulating post-operatively (LAPD, 2 days versus OPD, 2 days) (P = 0.021). Pancreas-specific complications and morbidity/mortality rates were similar. CONCLUSION: LAPD is a safe alternative to OPD in a select group of patients for an institution starting out with minimally invasive PD, and can be used to bridge the learning curve required for total laparoscopic PD.


Subject(s)
Laparoscopy/methods , Laparotomy/methods , Pancreatic Neoplasms/surgery , Pancreaticoduodenectomy/methods , Adult , Aged , Blood Loss, Surgical , Cohort Studies , Female , Humans , Laparoscopy/adverse effects , Laparotomy/adverse effects , Male , Middle Aged , Operative Time , Pancreatic Neoplasms/mortality , Pancreatic Neoplasms/pathology , Pancreaticoduodenectomy/adverse effects , Patient Selection , Postoperative Complications/epidemiology , Postoperative Complications/physiopathology , Propensity Score , Retrospective Studies , Risk Assessment , Survival Analysis , Treatment Outcome
3.
ANZ J Surg ; 88(6): E498-E502, 2018 Jun.
Article in English | MEDLINE | ID: mdl-28803449

ABSTRACT

BACKGROUND: Diffusion-weighted (DW) imaging is a functional magnetic resonance imaging (MRI) technique that detects lesions with high cellularity, such as malignant tumours. This prospective study was performed to compare the accuracy of DW-MRI with multidetector computed tomography (MDCT) in staging of colorectal cancer. METHODS: Thirty patients with histologically proven colorectal cancer were prospectively recruited. Each patient underwent both MDCT and DW-MRI of the abdomen-pelvis for primary staging. Images were evaluated for nodal and distant metastases. The reference standard was histopathological findings for nodal involvement and surveillance imaging for suspected hepatic metastases. RESULTS: The primary cancers were located in the rectum (n = 16, 53.3%), sigmoid colon (n = 9, 30%) and right colon (n = 5, 16.6%). For nodal metastases, the sensitivity and specificity of DW-MRI were 84.6% (95% confidence interval (CI): 54.6-98.1%) and 20.0% (95% CI: 2.5-55.6%) compared with 84.6% (95% CI: 54.6-98.1%) and 40.0% (95% CI: 12.2-73.8%) for MDCT. For liver metastases, the sensitivity and specificity for DW-MRI were 100.0% (95% CI: 63.1-100.0%) and 100% (95% CI: 84.6-100%) compared with 87.5% (95% CI: 47.4-99.7%) and 95.5% (95% CI: 77.2-99.9%) for MDCT. DW imaging altered the clinical management in three (10.0%) patients by detecting missed hepatic metastases in two patients and accurately diagnosing another patient with a hepatic cyst, mistaken for metastasis on MDCT. CONCLUSION: DW-MRI is more accurate for detecting hepatic metastases in colorectal cancer compared with MDCT.


Subject(s)
Colorectal Neoplasms/diagnostic imaging , Colorectal Neoplasms/pathology , Diffusion Magnetic Resonance Imaging/methods , Multidetector Computed Tomography/methods , Cohort Studies , Colorectal Neoplasms/surgery , Female , Humans , Male , Neoplasm Invasiveness/pathology , Neoplasm Staging , Preoperative Care/methods , Prospective Studies , Sensitivity and Specificity
4.
Surg Laparosc Endosc Percutan Tech ; 24(5): 452-6, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25275815

ABSTRACT

BACKGROUND: Laparoscopic total mesorectal excision (TME) remains a technically challenging procedure. This study aims to compare the surgical outcomes of the robotic-assisted laparoscopic (RAL) versus hand-assisted laparoscopic (HAL) techniques in performing TME for patients with rectal cancers. METHODS: A retrospective review of all patients who underwent RAL TME for rectal cancers was performed. These cases were matched for age, sex, and stage of malignancy with patients who underwent HAL TME. Data collected included age, sex, American Society of Anesthesiologists scores, comorbid conditions, types of surgical resections and operative times, perioperative complications, length of hospital stays, and histopathologic outcomes were analyzed. RESULTS: From August 2008 to August 2011, 19 patients, with a median age of 62 (range, 47 to 92) years underwent RAL TME. Eight (42.1%) patients received neoadjuvant chemoradiotherapy. The median docking and operative times were 10 (range, 3 to 34) and 390 (range, 289 to 771) minutes, respectively. There was 1 (5.3%) conversion to open surgery. The grade of mesorectal excision was histopathologically reported as complete in all 19 cases. Positive circumferential margin was reported in 1 (5.3%) patient.Comparing the 2 groups, more patients in the RAL group received neoadjuvant chemoradiotherapy (8 vs. 3; P=0.048). The operative times were longer in the RAL group (390 vs. 225 min; P<0.001). A higher proportion of patients in the HAL group required conversion to open surgery (5 vs. 1; P=0.180) and developed perioperative morbidities (3 vs. 7; P=0.269). The median length of hospitalization was comparable between both groups (RAL: 7 vs. HAL: 6 d; P=0.476).The procedural cost was significantly higher in the RAL group (US$12,460 vs. US$8560; P<0.001), whereas the nonprocedural cost remained comparable between the 2 groups (RAL: US$4470 vs. HAL: US$4500; P=0.729). CONCLUSIONS: RAL TME is associated with lower conversion and morbidity rates compared with HAL TME. The longer operating times and higher procedural costs are current limitations to its widespread adoption.


Subject(s)
Hand-Assisted Laparoscopy , Rectal Neoplasms/surgery , Robotic Surgical Procedures , Aged , Aged, 80 and over , Case-Control Studies , Conversion to Open Surgery/statistics & numerical data , Hand-Assisted Laparoscopy/economics , Humans , Intraoperative Complications , Length of Stay , Middle Aged , Neoadjuvant Therapy , Operative Time , Retrospective Studies , Robotic Surgical Procedures/economics
SELECTION OF CITATIONS
SEARCH DETAIL